Jack Reacher

Merck and Schering-Plough Make the Bad News About Vytorin Even Worse

As a Pharmacist, I see so much wrong with 1) the study, and 2) with how the drug company management handled it on Monday. The article in the Wall Street Journal has the management saying, "...oh well, back to the drawing board..." when it seems real clear to me that the drug does what they said it does. The companies should have defended the drug. The WSJ article mentioned that only one "panelist" gave the presentation, and it was not what was expected. The whole thing sounds fishy to me. Zetia works. It FURTHER lowers cholesterol in the blood. The study smells from here. But, hey...if people want to stop taking it and INCREASE blood levels of cholesterol---that's up to them. Something is not right here.